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The fungal Ccr4-NOT complex has been implicated in orchestrating gene expression
networks that impact on pathways key for virulence in pathogenic species. The activity
of Ccr4-NOT regulates cell wall integrity, antifungal drug susceptibility, adaptation to host
temperature, and the developmental switches that enable the formation of pathogenic
structures, such as filamentous hyphae. Moreover, Ccr4-NOT impacts on DNA repair
pathways and genome stability, opening the possibility that this gene regulator could
control adaptive responses in pathogens that are driven by chromosomal alterations. Here
we provide a synthesis of the cellular roles of the fungal Ccr4-NOT, focusing on pathways
important for virulence toward animals. Our review is based on studies in models
yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe, and two species
that cause serious human infections, Candida albicans and Cryptococcus neoformans.
We hypothesize that the activity of Ccr4-NOT could be targeted for future antifungal
drug discovery, a proposition supported by the fact that inactivation of the genes
encoding subunits of Ccr4-NOT in C. albicans and C. neoformans reduces virulence in the
mouse infection model. We performed bioinformatics analysis to identify similarities and
differences between Ccr4-NOT subunits in fungi and animals, and discuss this knowledge
in the context of future antifungal strategies.
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INTRODUCTION
Model fungal species, such as the yeasts Saccharomyces cerevisiae
and Schizosaccharomyces pombe, have served as powerful genetic
models for elucidating the fundamental principles of eukary-
otic cellular and molecular biology. In addition to these benign
species, the fungal kingdom also contains a number of species
that are pathogens of humans, other animals and plants. The
pathogenic fungal species have profound effects on the ecosys-
tem, as well as on human health (Brown et al., 2012; Fisher
et al., 2012; Kupferschmidt, 2012). In regards to human disease, a
small number of species is responsible for most infections, such
as Candida sp, the mold Aspergillus fumigatus, and the basid-
iomyces yeasts belonging to the Cryptococcus species complex
(Brown et al., 2012). In most cases, life-threatening disease is
seen in hosts with immunocompromised status; therefore fun-
gal infections have become a reason for substantial concern due
to the AIDS epidemic and new generation medical procedures
that compromise immune function. There are very few treatment
options, and mortality from systemic fungal disease remains high
in both the developed, and the developing world (Pfaller and
Diekema, 2010; Brown et al., 2012). Key mechanisms that impact
on the ability of fungi to successfully infect human hosts, sur-
vive immune attack, and resist treatments with antifungal drugs
include adaptation to growth at host temperature, the ability to
mount adaptive responses, genomic and metabolic plasticity, and
the capacity to change cell morphology and build and remodel the
cell surface, reviewed in Cooney and Klein (2008), Selmecki et al.
(2010), Gow and Hube (2012), O’Meara and Alspaugh (2012),
Morrow and Fraser (2013). Key regulators have been identified
that control these pathogenesis-enabling mechanisms, and many
act by modulating gene expression to enable the transitions in cell
physiology that favor pathogen survival and virulence. One such
regulator is the Ccr4-NOT complex.
Ccr4-NOT is a multisubunit, multifunctional eukaryotic reg-
ulator, which has been proposed to serve as a control node for
the integration of environmental signals that impinge on cell
physiology, as well as acting to coordinate multiple nuclear and
cytoplasmic steps in gene expression, reviewed in Collart and
Timmers (2004), Collart and Panasenko (2012), Collart et al.
(2013). The core Ccr4-NOT complex is composed of nine sub-
units, which perform roles in gene transcription (initiation and
elongation) (Bai et al., 1999; Badarinarayana et al., 2000; Denis
et al., 2001; Deluen et al., 2002; Swanson et al., 2003; Qiu et al.,
2004; Kruk et al., 2011), posttranscriptional regulation of mRNA
stability via poly(A) tail shortening or deadenylation (Tucker
et al., 2001, 2002; Chen et al., 2002), as well as several other
functions in gene regulation, such as export of mRNAs from the
nucleus to the cytoplasm (Kerr et al., 2011), and quality con-
trol through interactions with the exosome-dependent pathway
(Azzouz et al., 2009a). The architecture is such that the large Not1
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subunit serves as a scaffold that brings together the mRNA dead-
enylases Ccr4 and Caf1 (also known as Pop2) (Bai et al., 1999;
Tucker et al., 2001, 2002; Chen et al., 2002), the Not2-5 subunits
that mainly function in transcription and contain the Not4 E3
ubiquitin ligase (Collart and Struhl, 1993, 1994; Liu et al., 1998;
Bai et al., 1999; Badarinarayana et al., 2000; Hanzawa et al., 2001;
Deluen et al., 2002; Panasenko et al., 2006), and Caf40 and Caf130
(Chen et al., 2001). Such complexity of functions in gene regula-
tion, coupled with the fact that Ccr4-NOT activity impacts on
the transcriptome in a global way (Cui et al., 2008; Azzouz et al.,
2009b; Dagley et al., 2011), means that mutations in the genes
encoding Ccr4-NOT subunits lead to pleiotropic phenotypes.
In fungi these phenotypes include several that have important
implications for virulence of pathogenic species.
Here we provide a synthesis of the knowledge of Ccr4-NOT
roles in fungal biology and virulence. We draw on work from
S. cerevisiae, as the Ccr4-NOT complex has been mostly stud-
ied in this model species, and also review what we know about
Ccr4-NOT in pathogenic species. We argue that the pleiotropic
functions of this complex are beneficial in the context of fun-
gal pathogenesis in two ways: (i) by studying Ccr4-NOT, we
can uncover novel mechanistic links between cellular pathways
that impact on fungal virulence, and (ii) the pleiotropic func-
tions could be beneficial for targeting the complex with antifungal
molecules—inactivating Ccr4-NOT could simultaneously cripple
several functions important for virulence, resulting in more effi-
cient elimination of the pathogen. We therefore hypothesize that
the Ccr4-NOT complex could be a potentially attractive target for
antifungal drug discovery. The Ccr4-NOT complex is conserved
throughout eukaryotes, including between yeast and man. This
poses a potential problem, as inhibitors of its activity could be
toxic to the host. We performed bioinformatics analysis to revisit
the conservation between the fungal and animal Ccr4-NOT sub-
units, and identified several differences that could be exploited for
targeting the fungal complex specifically.
Ccr4-NOT AND THE FUNGAL CELL WALL
The fungal cell wall is an essential protective structure built from
carbohydrates (glucans and chitin), and glycosylated cell wall pro-
teins. The cell wall mediates interactions that enable attachment
of fungi to host cells, adherence to medical implants for the for-
mation of drug resistant biofilms, and immune recognition (Van
De Veerdonk et al., 2008; Finkel and Mitchell, 2011; Gow and
Hube, 2012). The cell wall is not present on human cells, and
as such is an attractive target for antifungal drug therapy. The
echinocandin drugs, which are used to treat fungal infections,
inhibit cell wall synthesis by acting on the enzyme 1,3 ß glucan
synthase (Douglas et al., 1997).
Early work in S. cerevisiae has shown that one of the most
prominent phenotypes of mutations in Ccr4-NOT relates to
defects in the integrity of the cell wall (Betz et al., 2002;
Kaeberlein and Guarente, 2002) (Figure 1). Mutants are sensitive
to cell wall damaging agents (the echinocandin drug caspofungin,
nikkomycin Z that inhibits chitin synthase, calcofluor white, caf-
feine, SDS), display cell lysis phenotypes, and their growth defects
can be suppressed by osmotic stabilization or overexpression of
PKC1 that encodes the kinase of the main fungal cell wall stress
FIGURE 1 | Multiple roles of Ccr4-NOT in pathways important for
virulence of human fungal pathogens. Gene regulation by the Ccr4-NOT
complex has been implicated in multiple survival mechanisms of fungal
pathogens, such as cell wall integrity, filamentous growth and survival of
nutrient and temperature stress. Direct assessment of the roles of
Ccr4-NOT in fungal biofilm formation and host-pathogen interactions is still
to come. Subunits of Ccr4-NOT are required for virulence of C. albicans and
C. neoformans in the mouse infection model.
response pathway (Betz et al., 2002; Kaeberlein and Guarente,
2002; Markovich et al., 2004; Parsons et al., 2004; Dagley et al.,
2011). The cell wall phenotypes are particularly obvious formuta-
tions in the mRNA deadenylase subunits of the complex, CCR4
and CAF1/POP2. Also, inactivation of the exonuclease activity of
Ccr4 by mutating one of the catalytic residues mimics a complete
deletion of the CCR4 gene for caspofungin sensitivity (Dagley
et al., 2011). The functions of the NOT sub-module and Caf40
and Caf130 are less clear, but there is evidence of involvement.
Inactivation of NOT5 leads to increased levels of expression of
genes encoding cell wall functions (Azzouz et al., 2009b), and
not4, caf40, and not3 mutants are sensitive to caffeine (Parsons
et al., 2004; Kapitzky et al., 2010). Mutations in genes encoding
proteins that act together with Ccr4-NOT in mRNA turnover,
for example the RNA helicase Dhh1 and the RNA binding pro-
tein Puf5 (also called Mpt5), also lead to phenotypes consistent
with cell wall defects (Moriya and Isono, 1999; Kaeberlein and
Guarente, 2002; Dudley et al., 2005; Stewart et al., 2007; Banuelos
et al., 2010; Traven et al., 2010; Lo et al., 2012). This argues that
mRNA decay of specific transcripts is key for maintaining fungal
cell wall integrity.
Ccr4 is also important for cell wall integrity in two prominent
human fungal pathogens, C. albicans and C. neoformans. In these
two pathogenic species, ccr4mutants display sensitivity to cell wall
inhibitors (calcofluor white, congo red, caspofungin), enlarged
cells and cell lysis defects (Panepinto et al., 2007; Dagley et al.,
2011). In C. albicans, similar phenotypes have also been observed
for the deletion of POP2/CAF1 (Dagley et al., 2011). Moreover,
the C. albicans the not5 mutant is more sensitive than the wild
type to calcofluor white, but more resistant to treatment with
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the ß-glucanase zymolyase, both phenotypes supportive of alter-
ations in the cell wall (Cheng et al., 2005). C. albicans mutants
inactivated for NOT3 display reduced ability to attach to a sil-
icone substrate, which points to changes in cell wall structure
and adherence properties (Finkel et al., 2012). In the most direct
demonstration roles of Ccr4-NOT in cell wall biogenesis, bio-
chemical analysis of cell wall composition showed that the C.
albicans ccr4 and caf1/pop2mutants display lower relative levels of
cell wall ß-glucans (Dagley et al., 2011). This result is consistent
with the sensitivity of the mutants to the echinocandin caspofun-
gin, which inhibits 1,3 ß-glucan synthesis. Given that S. cerevisiae
and C. neoformans ccr4 mutants are also sensitive to caspofun-
gin (Markovich et al., 2004; Panepinto et al., 2007; Dagley et al.,
2011), it is possible that in those yeasts also Ccr4 impacts on the
ß-glucan composition of the cell wall.
What are the target genes controlled by Ccr4-NOT to regu-
late cell wall biology? Several cell wall-related genes display altered
expression levels in ccr4 mutants, and some of the observed
changes could explain the cell wall ß-glucan phenotypes. These
data come from the S. cerevisiae system. Firstly, in the absence of
CCR4, KRE6 encoding a ß 1,6-glucan synthesis gene is expressed
at lower levels (Betz et al., 2002). Secondly, Ccr4 might be modu-
lating the activity of ß 1,3-glucan synthase (Figure 2). The levels
of two regulators of the GTPase Rho1, which is necessary for ß
1,3-glucan synthase activity, are differentially expressed in ccr4
mutants (Ito et al., 2011). The GTP exchange factor ROM2, an
activator for Rho1, is down-regulated, while the GTPase activat-
ing protein LRG1, a negative regulator of Rho1, is up-regulated.
These changes in gene expression likely lead to lower activity
of Rho1, which could have a negative impact on ß 1,3-glucan
synthase (Figure 2). Rho1 might also have a role in regulating
synthesis of ß 1,6-glucans, and is further required for signaling
through the PKC-dependent cell wall integrity pathway (Levin,
2011).
The deadenylase activity of Ccr4 negatively regulates gene
expression by causing shortening of the mRNA poly(A) tail,
thereby initiating decay (Goldstrohm and Wickens, 2008).
Therefore, a direct mRNA target of Ccr4 should be up-regulated
in the mutant. We would therefore argue that, of the known
affected genes, LRG1 is the most likely direct target of Ccr4 in
regards to cell wall phenotypes. Further support for this idea
comes from studies of Puf5, an RNA binding protein that binds
to 3′ untranslated regions (3′ UTRs) of mRNAs and recruits the
Ccr4-NOT complex for deadenylation and translational repres-
sion (Goldstrohm et al., 2006). Puf5 also negatively regulates
LRG1 levels (Stewart et al., 2007), and it could be doing so via its
interaction with Ccr4-NOT, but this needs to be experimentally
demonstrated (Figure 2). Whether LRG1 is a relevant Ccr4-target
gene in other fungal species remains to be studied.
It is very likely that the effects of Ccr4-NOT on the fungal cell
wall are complex, and regulation of multiple, functionally distinct
genes might be involved. The C. albicans not3 mutant displays
altered levels of several transcripts that encode cell wall proteins
(Finkel et al., 2012). Additionally, studies in C. albicans have sug-
gested that the effects of Ccr4 on another pathway, mitochondrial
biogenesis, might be linked to its functions in cell wall integrity
(Dagley et al., 2011). This, and work that followed from it, has
FIGURE 2 | The roles of Ccr4 in fungal cell wall integrity: is Ccr4 a key
regulator of glucan synthesis? The GTPase Rho1 is the regulatory subunit
of 1,3 ß-glucan synthase and might also have a role in the biogenesis of 1,6
ß-glucan. Rho1 is active in its GTP-bound form. The GTPase activating
protein (GAP) Lrg1 negatively regulates Rho1, while the GDP exchange
factor (GEF) Rom2 is a positive regulator. Ccr4 has been implicated in
repressing the expression of LRG1 and activating the expression of ROM2,
with both mechanisms acting to promote Rho1 activity. Ccr4 might be
repressing LRG1 via its deadenylase function, and the RNA binding protein
Puf5 might be acting to recruit the Ccr4-NOT complex to the LRG1 mRNA.
How Ccr4 acts to promote ROM2 expression is presently unclear.
revealed that mitochondrial activity in C. albicans impacts on cell
wall integrity and on the ability to respond to treatment with
cell wall inhibitors, including the echinocandin drug caspofun-
gin (Dagley et al., 2011; Qu et al., 2012). These studies provide
a case in point for our hypothesis that studying the pleoitropic
roles of Ccr4-NOT in fungi can reveal unexpected connections
and novel players in cellular pathways important in the context of
virulence. Studies in S. cerevisiae have revealed respiratory and
other mitochondrial defects for several Ccr4-NOT subunits, as
well as other factors of the mRNA decay pathway (for example
Dhh1) (Betz et al., 2002; Dimmer et al., 2002; Perrone et al.,
2005). It is therefore possible that, more generally, Ccr4-NOT and
the mRNA turnover machinery link mitochondrial activity with
cell wall integrity.
Ccr4-NOT AND THE MORPHOGENETIC SWITCH
Fungi have the ability to switch between developmental
states, which differ in cell morphology, cell surface structure,
pathogenicity and interaction with host immunity. One such
developmental switch that has been extensively characterized is
the yeast to hyphal transition, in which cells change cell mor-
phology from ovoid to elongated filaments (Sudbery, 2011). For
C. albicans, the hyphal transition is one of the most recognized
pathogenic attributes (Sudbery, 2011).
In S. cerevisiae, pseudohyphal differentiation in diploid strains
and agar invasion in haploid strains are two phenotypes that
depend on the morphogenetic switch. In large-scale mutant col-
lection screens, not5 mutants were found to display enhanced
filamentation on the surface of plates but no invasive growth
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(Jin et al., 2008), and caf130 mutants were identified as invasion-
defective (Ryan et al., 2012). Ccr4 and Pop2 impact on the
expression of a key cell surface molecule implicated in invasive
and pseudohyphal growth, the adhesin Flo11 (Lo et al., 2012).
Ccr4 might be promoting FLO11 transcription by inhibiting the
expression of two transcriptional repressors of FLO11, NRG1 and
NRG2 (Lo et al., 2012). Low Flo11 levels in the deadenylase
mutant alter the cell wall properties, and lead to low adherence
to polystyrene (Lo et al., 2012). Cells inactivated for the helicase
Dhh1 also display similar phenotypes (Park et al., 2006; Lo et al.,
2012). Collectively, these results argue that the mRNA decay path-
way plays important roles in linking morphogenesis and cell wall
regulation.
Studies in C. albicans support the S. cerevisiae data. Mutations
in CCR4, CAF1/POP2, NOT1, NOT3, and NOT5 give rise to cells
that are defective in transitioning from yeast to hyphal growth
(Cheng et al., 2003; Epp et al., 2010; Dagley et al., 2011). Substrate
adherence and hyphal growth are important for the formation of
C. albicans biofilms (Finkel and Mitchell, 2011). Given that Ccr4-
NOT impacts on both, it is possible that this complex controls the
ability of C. albicans to make biofilms.
The target genes of Ccr4-NOT for the filamentous growth
pathway are not known. The biogenesis of the cell wall is inti-
mately linked to filament formation. Therefore, the hyphal defects
of the ccr4-not mutants could be linked to altered cell wall struc-
ture and ß-glucan levels. Consistent with this idea are reports
that in C. albicans defects in cell wall ß-glucans lead to reduced
ability to form hyphae (Lussier et al., 1998; Herrero et al., 2004;
Umeyama et al., 2006). It is also possible that Ccr4-NOT hasmore
specific roles in orchestrating the changes in gene expression pro-
grams during the developmental switch from yeast to filaments.
Transcriptome-wide approaches to study howCcr4-NOT impacts
on gene regulation during the morphogenetic switch in both
S. cerevisiae and C. albicans will answer these questions. Based
on current knowledge, we predict that the role of Ccr4-NOT in
gene expression is conserved between these two divergent yeasts.
However, often, analysis of transcription factor function in dif-
ferent fungal species has revealed a large extent of evolutionary
change (Lavoie et al., 2009). How posttranscriptional gene regu-
lation has evolved in fungi is much less understood, and studies
of Ccr4-NOT could shed light on this exciting question.
THE Ccr4-NOT COMPLEX REPROGRAMS GENE EXPRESSION
TO PROMOTE STRESS ADAPTATION
When colonizing the human body, fungal pathogens face numer-
ous stressful conditions, such as nutrient limitation, higher tem-
perature, and low oxygen. In S. cerevisiae, C. neoformans and
C. albicans Ccr4-NOT has been implicated in the adaptation to
nutrient, temperature and oxygen stress, suggesting this com-
plex is a key player in adaptive response that mediate fungal
growth and survival in the host. In this section, we will briefly
touch on the S. cerevisiae work, as this has been reviewed before
(Denis and Chen, 2003; Collart and Timmers, 2004), and focus
more prominently on new knowledge gained in the pathogenic
species.
Glucose is the preferred carbon source for yeasts, which they
ferment by glycolysis. In S. cerevisiae the Ccr4-NOT complex
has important roles for growth in the absence of glucose (so
called non-fermentative growth), reviewed in (Denis and Chen,
2003; Collart and Timmers, 2004). Transcriptome profiling by
microarrays confirmed a role for Ccr4-NOT in adaptation to glu-
cose depletion, and also more generally in the response to stress
(Cui et al., 2008; Azzouz et al., 2009b). A major effect of Ccr4-
NOT on stress responsive gene transcription could be mediated
by interactions with the SAGA histone acetyltransferase com-
plex (Cui et al., 2008). Ccr4-NOT has also been implicated in
regulating the function of stress-responsive transcription factors,
such as Msn2 and Skn7 (Lenssen et al., 2002, 2005, 2007). In
the niches in the human body, glucose is scarce, and therefore
adaptation to alternative carbon sources is important. It remains
to be studied how exactly Ccr4-NOT controls the response to
non-fermentative conditions in pathogenic fungi. Transcriptome
analysis of the ccr4/ mutant in C. albicans showed that a
large proportion of the differentially expressed genes are related
to the function of mitochondria (Dagley et al., 2011), suggest-
ing a role in metabolism. Specific effects on gene expression of
mitochondrial functions have also been observed in S. cerevisiae
ccr4-not mutants (Cui et al., 2008). Interestingly, the transcrip-
tional profile of the ccr4/ mutant of C. albicans correlates
with the early response to hypoxia, suggesting a role for Ccr4 in
low oxygen conditions (Adnan Sellam and André Nantel, per-
sonal communication, manuscript in preparation). Hypoxia is
commonly encountered by fungal pathogens in the niches in the
human body, and the ability to respond to hypoxia is key for
virulence (Grahl et al., 2012).
In C. neoformans, the Ccr4-NOT complex impacts on the
expression of a key virulence factor, the laccase LAC1, a multi-
copper oxidase required the production of the protective pig-
ment melanin. Work on C. neoformans VAD1, the homolog of
S. cerevisiae DHH1, implicated Not1 as a repressor of LAC1
gene expression (Panepinto et al., 2005). The ccr4 mutant is
defective in laccase activity, but LAC1 mRNA induction is not
defective (Bloom and Panepinto, unpublished). These data sug-
gest that the defect in laccase production is posttranscriptional.
It appears therefore that in C. neoformans Ccr4-NOT regulates
LAC1 via Not1-dependent effects of transcription, and Ccr4-
dependent posttranscriptional control. The expression of the
LAC1 gene in C. neoformans is tightly regulated by glucose repres-
sion, suggesting that the role of Ccr4-NOT in glucose-regulated
gene expression is conserved between C. neoformans and
S. cerevisiae.
A key stress responsive function of Ccr4 in C. neoformans
is the response to temperature stress. This is key for virulence.
Mammals, such as us, are normally quite resistant to fungal infec-
tions, because most fungi do not grow optimally at our body
temperature of 37◦C. In order to colonize the human body niches,
fungal pathogens need to be able to adapt to growth at 37◦C.
The C. neoformans ccr4 mutant exhibits temperature sensi-
tivity, and is attenuated in virulence (Panepinto et al., 2007).
In response to temperature stress in S. cerevisiae, mRNAs that
encode ribosomal proteins and other protein synthesis factors are
destabilized by Ccr4, suggesting that mRNA decay is a mechanism
that promotes stress-responsive re-programming of mRNA pools
(Grigull et al., 2004). The destabilization of ribosomal protein
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mRNAs in response to temperature is also dependent on the RNA
polymerase II subunit Rpb4 (Goler-Baron et al., 2008; Harel-
Sharvit et al., 2010). The current paradigm is that, under stress
conditions, Rbp4 marks transcripts for rapid degradation via co-
transcriptional association. In C. neoformans the roles of Ccr4
and Rpb4 in the regulation stress responsive changes in mRNA
stability is conserved, suggesting that the coupling of mRNA syn-
thesis and decay is likewise conserved (Bloom et al., 2013). In
wild type C. neoformans, a shift from 30◦C to 37◦C is accom-
panied by acute and transient changes in mRNA abundance and
stability. Ribosomal proteinmRNAs are transiently repressed, and
ER stress mRNAs are transiently induced (Havel et al., 2011;
Bloom et al., 2013). Between 2 and 3 h post-shift, these mRNAs
return to pre-shift levels. In the ccr4mutant, ribosomal pro-
tein mRNAs accumulate and transient repression is absent. Those
mRNAs were found to be stable in the ccr4mutant, confirming
defects in mRNA degradation as the cause of their up-regulation.
Likewise, in a C. neoformans rpb4 mutant, mRNAs encoding
ribosomal proteins are stabilized, and the transient repression of
ribosomal protein transcript mRNA abundance that accompa-
nies temperature adaptation is attenuated (Bloom et al., 2013).
Furthermore, in ccr4 cells, increased ER stress mRNA abun-
dance persists past 3 h (Havel et al., 2011). The major ER stress
sensor is Kar2/BiP, an ER resident Hsp70 family member. In wild
type C. neoformans, the KAR2 transcript exhibits distinct changes
in mRNA stability in response to temperature stress (Bloom et al.,
2013). Under unstressed conditions, the KAR2 mRNA is very
stable, but is destabilized following the shift to 37◦C, through
Rpb4-dependent and -independent mechanisms, and the data is
consistent with a role in mRNA degradation limiting both the
intensity and the duration of the stress response. The destabiliza-
tion of KAR2 at peak mRNA abundance will prevent persistent
activation of the ER stress response such as that seen in the
ccr4 mutant. Phenotypically, there is no change in wild type
C. neoformans during this adaptation, and growth rate is main-
tained through the shift. In a ccr4 mutant, however, growth is
nearly arrested, cell morphology becomes aberrantly large and
buds fail to separate (Panepinto, unpublished). Clearly, Ccr4 in
C. neoformans is buffering phenotypic change in response to
environmental shift.
Ccr4-NOT AND GENOME STABILITY: ROLES IN FUNGAL
ADAPTATION DRIVEN BY CHROMOSOMAL ALTERATIONS?
Pathogenic fungi can acquire macro and micro-chromosomal
alterations that might be beneficial to their survival in the
host, or in the face of antifungal drug challenge, reviewed in
(Selmecki et al., 2010; Morrow and Fraser, 2013). Cells can
be generated that display changes in chromosome numbers
(aneuploid cells) or even the whole chromosomal set (ploidy
changes). Other chromosomal rearrangements, such as transloca-
tions, truncations, gene amplifications and loss of heterozygosity
(LOH) are also observed. Pathways that impact on genome sta-
bility (DNA replication, damage and repair mechanisms) and
cell division (cell cycle control mechanisms) are expected to
have an impact on the ability of fungal pathogens to adapt by
chromosomal alterations. Work in S. cerevisiae and S. pombe
implicates Ccr4-NOT in the regulation of genome stability.
Data in C. neoformans is consistent with this function, as ccr4
mutant cells are sensitive to DNA damaging agents (Panepinto,
unpublished).
Mutations in the Ccr4-NOT complex have been repeatedly
found in S. cerevisiae screens that used the deletion collection to
find genes that control susceptibility to DNA damaging agents, as
well as by researchers using candidate gene approaches (Bennett
et al., 2001; Betz et al., 2002; Hanway et al., 2002; Hartman and
Tippery, 2004; Parsons et al., 2004; Westmoreland et al., 2004;
Mulder et al., 2005; Traven et al., 2005; Woolstencroft et al.,
2006; Gaillard et al., 2009). In S. pombe, mutations in Ccr4-NOT
result in similar DNA damage response phenotypes (Takahashi
et al., 2007; Deshpande et al., 2009). Genetic interactions between
genes encoding Ccr4-NOT subunits and genes of the DNA dam-
age checkpoint and repair pathways also support an important
role for Ccr4-NOT in DNA damage responses (Traven et al.,
2005; Pan et al., 2006; Woolstencroft et al., 2006; Gaillard et al.,
2009).
How does Ccr4-NOT activity regulate DNA damage
responses? Studies from the S. cerevisiae system suggest a
complex scenario, with three possible mechanisms that are not
mutually exclusive. Firstly, it seems that Ccr4-NOT has a general
(non-gene-specific) roles in transcription-coupled repair (TCR)
(Gaillard et al., 2009). The TCR roles could be functionally linked
to the function of Ccr4-NOT in transcriptional elongation,
but the exact mechanism remains to be understood (Gaillard
et al., 2009). Secondly, Ccr4-NOT has gene-specific roles in
the response to DNA replication stress: Ccr4-NOT is needed
for the induction of ribonucleotide reductase (RNR) genes,
(Mulder et al., 2005; Woolstencroft et al., 2006; Kruk et al., 2011).
The effects of Ccr4-NOT on the expression of RNR genes are
transcriptional and posttranscriptional. Ccr4 might be acting to
inhibit the expression of the transcriptional repressor of the RNR
genes, CRT1, by shortening its mRNA poly(A) tail (Woolstencroft
et al., 2006). In regards to transcriptional control, in absence of
Not4 recruitment of RNA polymerase II and the TATA binding
protein (TBP) to the promoter of RNR3 in response to HU
treatment is defective (Mulder et al., 2005). It has been shown
more recently that Ccr4 and Not5 are found at the RNR3 gene
in response to MMS, supporting a direct role in transcription of
this gene upon DNA damage (Kruk et al., 2011). The third mech-
anism relates to a co-factor role for Pop2/Caf1 in regulating the
subcellular localization of ribonucleotide reductase in response
to inhibition of DNA replication (Takahashi et al., 2007). Ccr4
also appears to have some role in this process (Takahashi et al.,
2007).
In C. neoformans, multiple DNA damage-related mRNAs were
found up regulated in the ccr4 strain by microarray analy-
sis (Havel et al., 2011), suggesting conservation of a role for
the mRNA decay arm of the Ccr4-NOT complex in genome
integrity. C. neoformans lacks an ortholog of CRT1, and induces a
basidiomycete-specific ribonucleotide reductase small subunit in
response to HU treatment, rather than the retained ascomycete-
like gene (Zulkifli et al., 2012). An effect of CCR4 deletion on the
regulation of these genes has yet to be determined. Further studies
will define the extent of conservation between C. neoformans and
the ascomycete yeasts.
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The implication of the roles of Ccr4-NOT in genome sta-
bility is that in the absence of this complex, genome instability
should increase, causing higher chromosomal rearrangements.
Increased LOH has been shown in the S. cerevisiae ccr4 and pop2
mutants, but not for all markers tested, and wasmost pronounced
for a locus on chromosome XII (Andersen et al., 2008). The
increased LOH was suggested to be linked to the impact of Ccr4
and Pop2 on maintenance of dNTP pools: chromosome XII con-
tains the rDNA repeat, and it was suggested that the stability
of this repeat might be sensitive to nucleotide levels (Andersen
et al., 2008). Higher chromosomal instability could favor adap-
tation of pathogens, such as C. albicans and C. neoformans to
the host environment and antifungal drug stress. Interesting in
this context is a recent report that suggests that in S. pombe
and S. cerevisiae, Ccr4-NOT is necessary for ensuring survival of
cells that contain chromosomal aneuploidies (Tange et al., 2012).
Mutants in the NOT2, NOT3, and CAF40 genes were particularly
affected. The deadenylase subunits CCR4 and POP2 also likely
have a role, but this could not be precisely determined due to
non-specific effects of deadenylase activation in the assays used
(Tange et al., 2012). Bone-fide DNA repair genes were also found
to be required for growth of aneuploid cells, and it was sug-
gested that the DNA damage response functions of Ccr4-NOT
are linked with the roles of the complex in survival of aneuploids
(Tange et al., 2012). These results suggest that some forms of
chromosomal rearrangements, such as changes to copy numbers,
would not be tolerated in the absence of Ccr4-NOT. This could
be important in the context of fungal virulence and antifungal
drug tolerance, as aneuplodies are observed frequently, and have
been shown in some cases to confer increased resistance to drug
treatments, reviewed in Selmecki et al. (2010), Morrow and Fraser
(2013).
WOULD Ccr4-NOT BE AN APPROPRIATE TARGET FOR
ANTIFUNGAL DRUG DEVELOPMENT?
The phenotypes of the mutants argue yes. As discussed above,
inactivation of Ccr4-NOT function cripples several pathways
important for fungal virulence. Moreover, inactivation of CCR4
in C. albicans and C. neoformans, as well as NOT5 in C. albicans
resulted in significantly crippled virulence in mice (Cheng et al.,
2005; Panepinto et al., 2007; Dagley et al., 2011). In addition,
mutation of CCR4 causes hypersensitivity to the echinocandin
drug caspofungin in S. cerevisiae, C. albicans and C. neofor-
mans (Markovich et al., 2004; Panepinto et al., 2007; Dagley
et al., 2011), suggesting that targeting Ccr4 could be beneficial
for combinatorial therapy with the echinocandins. The polyene
amphotericin B and the ergosterol biosynthesis inhibitors from
the azole family of drugs are the other two classes of antifungals
important in the clinical context. An early report in S. cerevisiae
showed sensitivity of the ccr4 mutant to the polyene drug nys-
tatin, which binds to membrane ergosterol (Betz et al., 2002).
Understanding how Ccr4-NOT mutants in pathogens respond to
azoles and polyenes awaits further experimentation.
Fungi are eukaryotes and many fundamental cellular pathways
are conserved with animals. This close evolutionary relationship
poses a problem when fungi become our pathogens, because
compounds that inhibit fungal cells can cause host toxicity.
The Ccr4-NOT complex is a conserved eukaryotic regulator and
potentially, targeting subunits of this complex would result in
toxic effect in humans. To address this, we performed a detailed
bioinformatic analysis of the conservation of the Ccr4-NOT sub-
units with animals and within the fungal kingdom. Most the
key components of the Ccr4-NOT complex (Ccr4, Caf1/Pop2,
Not1, Not2, Not3, Not4, Caf40) were already present before
the divergence of fungi and animals (Figure 3), and are readily
identified in both groups. However, several fungi-specific dif-
ferences are noteworthy. The animal CNOT10 and CNOT11
were present in the ancestor, but lost in fungi, whereas Not5
and Caf130 are specific for a sub-group of fungi. While previ-
ous analysis realized that Not5 and Caf130 are not conserved
between S. cerevisiae and animals (Denis and Chen, 2003; Collart
and Timmers, 2004), our analysis shows that the acquisition of
these two genes is specific for the Saccharomycetes, which con-
tain S. cerevisiae and Candida species, but not other important
pathogens such as Aspergillus and Cryptoccous species (Figure 3;
Supplemental Table 1). Caf130 shows no relevant similarity to
any other protein and is a highly specific invention (we note
that occasionally the fungal Caf130 and the animal CNOT10
are listed as homologs (Miller and Reese, 2012), but there is
no relevant sequence conservation between the two proteins).
Caf130 is fungal-specific, which makes it an interesting can-
didate for drug development. The function of Caf130 is not
clear at the moment, and the S. cerevisiae mutant showed a
transcriptional profile similar to the wild type (Azzouz et al.,
2009b). However, the caf130 mutant of S. cerevisiae was recently
reported to be defective for invasion (Ryan et al., 2012), a
phenotype known to affect the virulence potential of C. albi-
cans. It is noteworthy that Caf130 is not present outside the
Saccharomycetes, which would limit its usefulness if the aim were
FIGURE 3 | The evolution of the Ccr4-NOT complex. A schematic tree
indicating the evolution of the indicated groups based on our current
understanding; the presence of the respective members is indicated to
emphasize fungi-specific gains (Caf130, Not5), as well as loss (CNOT10,
CNOT11) due to their prior presence in the Amoebozoa. Identifiers for
sequences supporting this are shown in Supplemental Table 1. The bright
shading of Ccr4 in the Amoebozoa indicates the lack of the LRR domain;
since this is essential for the binding of Pop2/Caf1 and thus to Not1, this
implies that the function of the Ccr4-NOT complex as such could be
specific to fungi and animals.
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FIGURE 4 | Comparison of Ccr4-Caf1-Not1 interaction domains between
humans and pathogenic fungi. (A) A schematic overview of the
Ccr4-Caf1-Not1 interactions based on S. cerevisiae, illustrating the
interactions between the Ccr4 LRR domain, Caf1, and the Not1 MIF4G fold
domain as reported in Basquin et al. (2012) and Petit et al. (2012); the gray
shading indicates the interactions. (B) Alignment of the corresponding
regions of Ccr4, Caf1, and Not1 in yeast and several fungal pathogens
(Continued)
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FIGURE 4 | Continued
compared to the human homologs. The sites described to be
responsible for the function and/or protein-protein interactions in yeast
(Clark et al., 2004; Basquin et al., 2012) are indicated by red dots.
Color shades represent sequence conservation with a 20% cutoff
value as implemented in JalView (Clamp et al., 2004). (C) The DEDD
motif of Caf1, as well as the histidine that aids in formation of the
cofactor binding pocket (Jonstrup et al., 2007; Horiuchi et al., 2009),
are highlighted in red or yellow, respectively. This illustrates the loss
of these residues in the Saccharomycetes, but not in other fungal
groups. The sequences represent a subset from a full alignment of all
sequences. The amino acids are indicated at the start of each block
in (B), and the highlighted amino acid residue numbers are given in
brackets for each sequence in (C). All alignments are based on the
full sequence selection of fungi and animal sequences as given in
Supplemental Table 1, and were aligned with muscle (version 3.8.31)
(Edgar, 2004), using default settings. Shown sequences were
subsequently selected and only-gap sites removed.
a pan-fungal inhibitor. In contrast to Caf130, Not5 shows con-
siderable sequence similarity to Not3 from animals and fungi,
and has arisen from a gene duplication event at the base of the
Saccharomycetes (Supplemental Figure 1). Our analysis is consis-
tent with previous observations that it is not easily clear whether
Not3 or Not5 are more similar to Not3 in organisms with only
one copy, as the two genes show similar levels of sequence diver-
gence. Fungi outside the Saccharomycetes, such as Aspergillus
and Cryptococcus have only one copy of this gene, which we
call NOT3/5. While they are easily identifiable as homologs,
the sequence conservation of the Not3/Not5 subunit(s) is not
very high between organisms, including between fungi and ani-
mals (Supplemental Figure 1). Inactivation ofNOT5 has a strong
impact on fungal fitness, and in C. albicans the mutant has a
cell wall and a virulence defect (Cheng et al., 2005). Collectively,
the sequence divergence and roles in virulence suggest that the
Not5/Not3 proteins could be targets of interest in the context of
antifungal therapy.
We next investigated the level of sequence conservation for the
deadenylase subunits between humans and the fungal pathogens
(Cryptococcus, Candida, and Aspergillus; Figure 4). Despite sig-
nificant differences in length, the Ccr4/Caf1/Not1 interacting
domains are conserved between the proteins of fungi and humans
(Figures 4A,B) (Basquin et al., 2012).We focused on the sequence
regions known to hold the essential sites for the interactions
between Ccr4-Caf1 and Caf1-Not1, as determined in a recent
structural study (Basquin et al., 2012). The Caf1-Not1 interaction
anchors Ccr4 into the Ccr4-NOT complex, and the interac-
tions between these three subunits are essential for deadenylation
and growth of S. cerevisiae (Basquin et al., 2012). The high
level of conservation of the sites in Ccr4, Pop2/Caf1, and Not1
required for the interactions indicate that functionality of these
regions is likely conserved for fungi and animals (Figure 4B).
Despite the high similarity, there is a level of variation in the
sequences, which could prove beneficial to design compounds
to specifically target the fungal complex. We note that loss of
the catalytic deadenylase activity of Caf1/Pop2 and the DEDD
motif, which is archetypical for this family of deadenylases, is
true only for the Saccharomycetes (which include S. cerevisiae
and the Candida species), but not the other fungal pathogens
(Figure 4C).
The presence of CNOT10 in organisms other than animals
(Figure 3) indicates its loss in fungi and potential functional
replacement with Caf130, for which no similar proteins out-
side the Saccharomycetes could be found. This might go in
accordance with the differences observed in Not1; whilst the C-
terminus, the binding site of Caf1, Ccr4, and Not2-5 (Basquin
et al., 2012), is relatively conserved, the N-terminus - which har-
bors the Caf40 and CNOT10 /CNOT11, and possibly also the
Caf130, binding sites (Nasertorabi et al., 2011; Bawankar et al.,
2013) - is reduced in fungi compared to animals (Figure 4A).
In the Candida group, the proteins lack approximately 180
amino acids at the N-terminal part compared to S. cerevisiae
(Supplemental Figure 2 shows an alignment of Not1 sequences
from S. cerevisiae, representative fungal pathogens and humans).
The Not1 MIF4G region in Not1 contains several sites known
to be essential for binding of Caf1 (to which Ccr4 binds) in
both fungi and animals (Basquin et al., 2012; Petit et al., 2012)
(Figure 4A).
In conclusion, while the Ccr4-NOT complex is generally con-
served between yeast and humans, some subunits are fungal-
specific, and some sequence variation can be observed in the
conserved subunits. These observations suggest that this com-
plex might be explored in the context of antifungal therapy. It is
noteworthy that developing antifungal drugs against targets con-
served with humans has been done successfully: the target of the
commonly used azole drugs, sterol 14 α-demethlyase, is an evo-
lutionarily conserved enzyme required for ergosterol/cholesterol
synthesis. However, the inhibition of the fungal enzyme by azoles
is higher than inhibition of the human homolog (Parker et al.,
2008; Warrilow et al., 2013). It might also be useful to think about
Ccr4-NOT in the context of combinatorial therapy with con-
ventional antifungal drugs, such as the echinocandins. One can
imagine that the deadenylase activities of Ccr4 could be targeted,
and the levels of inhibition adjusted so not to cause adverse effects
on human cells, but rather specifically kill fungi in combination
with other, fungal-specific drugs.
CONCLUSIONS AND OUTLOOK
Ccr4-NOT has been implicated in the ability of C. albicans and
C. neoformans to cause disease, despite fundamental differences
in the pathogenic processes of these two human pathogens. For
example, C. albicans is a human commensal and the temper-
ature of the human host is not sensed as a stressor. In con-
trast, C. neoformans is an environmental fungus, and the shift
from environmental temperature to human core body temper-
ature is sensed as a stressor and involves reprogramming of
mRNA pools. Both C. albicans and C. neoformans encounter
macrophages. C. neoformans has evolved the ability to survive
and even proliferate within the macrophage, whereas C. albicans
utilizes the yeast-to-hyphae morphogenetic transition to escape
the phagocyte. Though the role of Ccr4 in the survival of C.
neoformans or C. albicans in macrophages has not been investi-
gated, the stress sensitivity of the C. neoformans mutant and the
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lack of morphogenetic capacity of the C. albicans mutant predict
that the macrophage-pathogen interaction would lead to elim-
ination of the pathogen. This illustrates how the pleoiotropic
phenotypes of the ccr4-not mutants might be beneficial in tar-
geting diverse pathogens, in addition to inactivating several pro-
cesses important for virulence. Further studies of Ccr4-NOT
function in C. albicans and C. neoformans, as well as exten-
sion to other pathogenic species, such as the molds and the
dimorphs, are likely to be informative for understanding fun-
gal pathogenesis and provide further insight how this complex
or a pathway that it regulates could be targeted for improving
treatments.
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Supplemental Figure 1 | The relationship between Not3, Not5, and CNOT3
with respect to sequence divergence and phylogenetics. (A) Both Not3
and Not5 are present only in the Saccharomycetes. Sequence accession
numbers are given in Supplemental Table 1. The alignment was
performed by muscle (version 3.8.31) (Edgar, 2004) using default settings.
The color shades represent sequence conservation with a 20% cutoff
value, and the level of conservation is shown, as implemented in JalView
(Clamp et al., 2004). (B) Phylogenetic analysis reveals that the Not3 and
Not5 are products of a gene duplication (the duplication event is indicated
by a red dot), and show similar levels of sequence divergence, supporting
the idea that it is not clear whether the Saccharomycetes Not3 or Not5 is
more similar to the single-copy Not3 (CNOT3). The sequence accession
numbers are given in Supplemental Table 1. The sequences were
aligned with muscle (version 3.8.31) (Edgar, 2004) using default
conditions, and divergent regions were removed using trimal (1.2rev59)
(Capella-Gutierrez et al., 2009) with the “-automated1” setting. The tree
was calculated in MrBayes (version 3.2.1) (Ronquist and Huelsenbeck,
2003) using the amino acid mixture model with 10.000.000 generations,
with 25% discarded as burn-in during the consensus tree calculation;
support values shown are posterior probabilities.
Supplemental Figure 2 | Divergence of Not1 between fungi and humans.
Not1 shows different profiles of conservation, which goes in accordance
with the binding domains of conserved (Ccr4, Caf1) and divergent (Caf40,
Caf130 vs. CNOT10) binding partners. The alignment was performed by
muscle (version 3.8.31) (Edgar, 2004) using default settings, color
shades represent sequence conservation with a 20% cutoff value as
implemented in JalView (Clamp et al., 2004); accession numbers of all
sequences are given in Supplemental Table 1.
Supplemental Table 1 | Table accessions. Accession numbers and
sequence data were retrieved from the yeast gene order browser
(http://ygob.ucd.ie/) (Byrne and Wolfe, 2005), the Candida gene order
browser (http://cgob.ucd.ie/) (Maguire et al., 2013) or the NCBI RefSeq
database.
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